← All peptides
Cognitive & Nootropic
Longevity & Anti-aging
Research Chemical

DSIP

Also known as: DSIP, Delta Sleep-Inducing Peptide

Delta Sleep-Inducing Peptide is a small neuromodulatory nonapeptide studied for its effects on sleep architecture, stress hormones, and pain modulation.

Last updated

Mechanism of Action

DSIP is a nine-amino-acid peptide that crosses the blood-brain barrier and is thought to act as a neuromodulator influencing delta-wave (slow-wave) sleep. It appears to modulate the hypothalamic-pituitary-adrenal axis, lowering circulating corticotropin and cortisol while affecting somatostatin and other neuroendocrine outputs. Research also implicates interactions with opioidergic and GABAergic signaling, contributing to its reported antinociceptive and stress-buffering effects, though its precise receptor target remains undefined.

Half-life
Very short; roughly 7-15 minutes in circulation
Administration Routes
subcutaneous, intranasal
Research Status
Research Chemical

Reported Benefits

  • Studied for improving slow-wave sleep quality
  • May reduce stress-related cortisol elevation
  • Reported antinociceptive (pain-dampening) effects in models
  • Investigated for normalizing disrupted circadian rhythm
  • May ease symptoms during opioid or alcohol withdrawal in studies

Potential Side Effects

  • Headache or grogginess
  • Dizziness
  • Transient changes in mood or alertness
  • Injection-site irritation

Common Dosing

Research literature commonly references subcutaneous doses of about 100-300 mcg before sleep. For research use only; not personal medical advice.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Known hypersensitivity to the peptide
  • Pregnancy or breastfeeding
  • Concurrent use of strong sedatives without oversight
  • Delta sleep-inducing peptide (DSIP): a still unresolved riddle

    2006

    View
  • Synthetic delta-sleep-inducing peptide improves sleep in insomniacs

    1981

    View
  • Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia

    1987

    View
  • Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study

    1992

    View
  • Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study

    1984

    View

It is studied mainly for promoting deeper slow-wave sleep, modulating the stress hormone axis, and dampening pain signaling in experimental models.

Its circulating half-life is only minutes, so it acts quickly but transiently; effects on sleep and stress hormones are studied rather than guaranteed.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.